Retinopathy of Prematurity research hub
6 indexed studies · 3 currently recruiting
- recruiting
An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Used in Preterm Babies With Retinopathy of Prematurity in the United Kingdom (UK)
This study looks at how a medicine called aflibercept (Eylea) is used for premature babies in the UK who have an eye condition called Retinopathy of Prematurity (ROP). It's an information-gathering study to see how many babies are treated this way and to consider future research.
United Kingdom - recruiting
European Disease Registry on Retinopathy of Prematurity (ROP)
This study is gathering information about premature babies across Europe who need treatment for a serious eye condition called Retinopathy of Prematurity (ROP). It helps doctors understand how the condition affects babies and what treatments are used.
Austria · Bulgaria · Estonia - recruitingPHASE2
Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity
This study looks at whether a medicine called propranolol can help prevent a serious eye condition called Retinopathy of Prematurity (ROP) in very premature babies. ROP can sometimes lead to blindness. Doctors want to see if this oral medicine can reduce the need for eye surgery or injections.
Germany · Switzerland · Turkey (Türkiye) - recruiting
The investigation of eye tear film proteins to see if there is an association with the stage of an eye condition called Retinopathy of Prematurity (ROP) which can occur in some premature babies; and the investigation of eye nerve development in these babies
This study looks for early signs of an eye condition called Retinopathy of Prematurity (ROP) in premature babies. Researchers will check proteins in tears and how babies' eyes respond to light to find new ways to detect ROP and prevent vision problems early on.
United Kingdom · England · Scotland - ongoing, recruitingTherapeutic confirmatory (Phase III)
(20275) An extension study to evaluate the long-term outcomes of subjects who received treatment for retinopathy of prematurity in Study 20090
This study is looking at the long-term health of children, up to five years old, who received treatment for an eye condition called retinopathy of prematurity (ROP). Specifically, it will check their eyesight and overall development to see how well they are doing after treatment.
Sweden · Italy · Portugal - active not recruitingPHASE2
Bevacizumab Treatment For Type 1 ROP
This study looks at a special medicine (bevacizumab) for severe ROP, a eye condition in premature babies. We want to find the best low dose to help blood vessels grow normally and prevent vision problems, comparing two different amounts of the medicine.
United States · Canada